Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Tarsus Pharmaceuticals Inc (NASDAQ: TARS) closed at $47.10 in the last session, down -0.11% from day before closing price of $47.15. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 0.68 million shares were traded. TARS stock price reached its highest trading level at $49.9 during the session, while it also had its lowest trading level at $46.915.
Ratios:
We take a closer look at TARS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.39 and its Current Ratio is at 4.42. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 20, 2023, initiated with a Neutral rating and assigned the stock a target price of $19.
On July 18, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $44.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when LINK WILLIAM J PHD sold 35,000 shares for $26.08 per share. The transaction valued at 912,961 led to the insider holds 0 shares of the business.
FLYING L PARTNERS XI LLC bought 35,000 shares of TARS for $939,750 on Aug 12 ’24. On Jun 18 ’24, another insider, Farrow Jeffrey S, who serves as the insider of the company, sold 10,445 shares for $27.47 each. As a result, the insider received 286,924 and left with 18,136 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARS now has a Market Capitalization of 1807566080 and an Enterprise Value of 1588642048. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.88 while its Price-to-Book (P/B) ratio in mrq is 8.04. Its current Enterprise Value per Revenue stands at 8.683 whereas that against EBITDA is -13.311.
Stock Price History:
The Beta on a monthly basis for TARS is 0.99, which has changed by 0.6004077 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, TARS has reached a high of $57.28, while it has fallen to a 52-week low of $20.08. The 50-Day Moving Average of the stock is -5.23%, while the 200-Day Moving Average is calculated to be 20.81%.
Shares Statistics:
According to the various share statistics, TARS traded on average about 629.05K shares per day over the past 3-months and 613270 shares per day over the past 10 days. A total of 38.35M shares are outstanding, with a floating share count of 33.09M. Insiders hold about 13.77% of the company’s shares, while institutions hold 102.11% stake in the company. Shares short for TARS as of 1740700800 were 7342164 with a Short Ratio of 11.67, compared to 1738281600 on 7339031. Therefore, it implies a Short% of Shares Outstanding of 7342164 and a Short% of Float of 19.830000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
